Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,469 | -26,754 | -17,647 | -22,799 | -14,059 |
| Depreciation Amortization | 632 | 570 | 369 | 361 | 308 |
| Income taxes - deferred | N/A | -164 | N/A | N/A | N/A |
| Accounts receivable | -4,055 | 12,511 | -14,469 | -59 | N/A |
| Accounts payable and accrued liabilities | 1,257 | 764 | -332 | 1,360 | -91 |
| Other Working Capital | -32,121 | 21,893 | 63,537 | 6,096 | -791 |
| Other Operating Activity | 7,289 | -9,886 | 18,296 | 653 | 1,927 |
| Operating Cash Flow | $-52,467 | $-1,066 | $49,754 | $-14,388 | $-12,706 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,462 | -1,698 | -1,950 | -560 | -621 |
| Purchase Of Investment | -59,317 | -117,582 | -43,925 | N/A | N/A |
| Sale Of Investment | 71,617 | 110,405 | N/A | N/A | N/A |
| Investing Cash Flow | $9,838 | $-8,875 | $-45,875 | $-560 | $-621 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -1,158 |
| Common Stock Issued | 32,166 | 48,511 | 4,090 | 15,221 | 25,774 |
| Financing Cash Flow | $32,166 | $48,511 | $4,090 | $15,221 | $24,616 |
| Exchange Rate Effect | -2,144 | -1,581 | 553 | -267 | -415 |
| Beginning Cash Position | 74,867 | 37,878 | 29,356 | 29,350 | 18,474 |
| End Cash Position | 62,260 | 74,867 | 37,878 | 29,356 | 29,349 |
| Net Cash Flow | $-12,607 | $36,989 | $8,522 | $6 | $10,875 |
| Free Cash Flow | |||||
| Operating Cash Flow | -52,467 | -1,066 | 49,754 | -14,388 | -12,706 |
| Capital Expenditure | -2,462 | -1,698 | -1,950 | -560 | -621 |
| Free Cash Flow | -54,929 | -2,764 | 47,804 | -14,948 | -13,326 |